Ketepatan dan Kecukupan Profilaksis Venous Thromboembolism berdasar Pedoman American College of Chest Physicians di Ruang Rawat Intensif Rumah Sakit Dr. Hasan Sadikin Bandung
Abstract
Pasien sakit kritis adalah pasien dengan kondisi mengancam nyawa yang membutuhkan penanganan khusus di ruang rawat intensif (intensive care unit; ICU). Hampir semua pasien kritis yang dirawat di ICU memiliki beberapa faktor risiko yang meningkatkan venous thromboembolism (VTE). Venous thromboembolism merupakan komplikasi yang tersembunyi pada pasien sakit kritis yang dapat meningkatkan angka morbiditas dan mortalitas. Venous thromboembolism dapat dicegah dengan tromboprofilaksis yang sesuai dan adekuat. Pedoman pencegahan VTE dikembangkan dalam beberapa dekade salah satunya oleh American College of Chest Physicians (ACCP). Tujuan penelitian ini mengetahui kepatuhan berdasar ketepatan dan kecukupan pemberian tromboprofilaksis terhadap pedoman ACCP. Penelitian deskiripsi observasional retrospektif dilakukan pada Oktober–Desember 2018 terhadap 284 pasien yang dirawat di Unit Perawatan Intensif Rumah Sakit Dr. Hasan Sadikin Bandung periode Januari–Desember 2016. Secara keseluruhan proporsi pasien di ICU yang mendapatkan tromboprofilaksis, yaitu 36,1%. Angka kepatuhan pemberian profilaksis VTE di ICU berdasar pedoman ACCP adalah 21,5%. Pemberian profilaksis VTE yang tidak adekuat terdapat pada 12,4% pasien, sedangkan pemberian profilaksis yang tidak sesuai terdapat pada 2,2% pasien. Simpulan, kepatuhan pemberian tromboprofilaksis terhadap pedoman yang diterbitkan ACCP masih rendah.
Adequacy and Accuracy of Venous Thromboembolism Prophylaxis based
on American College of Chest Physicians Guideline at Intensive Care Unit of Dr. Hasan Sadikin General Hospital Bandung
Critically ill patients are patients with life-threatening conditions that require special treatment in the intensive care unit. Almost all critical patients admitted to the ICU have several risk factors that increase the occurrence of Venous thromboembolism (VTE). Venous thromboembolism is a hidden complication in critically ill patients that can increase morbidity and mortality. Venous thromboembolism can be prevented with appropriate and adequate thromboprophylaxis. Several thromboprophylaxis guidelines have been developed during the last decades, including the American College of Chest Physicians (ACCP) guideline. The purpose of this study was to determine the compliance to ACCP guideline by measuring the the accuracy and adequacy of thromboprophylaxis. This retrospective observational descriptive study was conducted from October–December 2018 on 284 patients treated in the Intensive Care Unit of Dr. Hasan Sadikin General Hospital Bandung. The overall proportion of patients in ICU who received thromboprophylaxis was 36.1%. The compliance rate of VTE prophylaxis in ICU based on ACCP guideline was 21.5%. Inadequate VTE prophylaxis was seen in 12.4% of patients while inappropriate prophylaxis was identified in 2.2% of patients. Hence, the compliance to standards on thromboprophylaxis based on the ACCP guideline is still low in this hospital.
Keywords
Full Text:
PDFReferences
Adriance SM, Murphy CV. Prophylaxis and treatment of venous thromboembolism in critically ill. Int J Crit Illn Inj Sci. 2013;3:143–51.
Moser KM. Venous thromboembolism. Dalam: Kluwer W, penyunting. Marino’s Edisi ke-4. The ICU Book. Philadelphia: Lippincott Williams & Wilkins. 2014. Hlm. 97–105.
Kaushansky, K, Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Prchal JT. Venous thrombosis. Dalam: Raskob GE, Hull RD; Pineo GF, penyunting. Williams hematology. Edisi ke-8. China: The McGraw-Hill Companies, Inc.P; 2010. hlm. 2700–20.
Boodi M, Peris A. Deep vein thrombosis on intensive care. Adv Exp Med Biol. Switzerland. 2015;2:167–81.
Hutajulu SV. Thromboembolism prophylatic. Dalam: Pangalila FJV, Mansjoer A, penyunting. Penatalaksanaan sepsis dan syok septik (optimalisasi Fashugbid). Jakarta: Perdici; 2017. hlm. 28–32.
Ting Y, Dylan M, Lin J, Dubois R. Hospitals’ compliance with prophylaxis guidelines for venous thromboembolism. Am I Health-Syst Pharm. 2007;24:69–74.
Minet C, Potton L, Bonadona A, Roy RH, Somohano CA, Lugosi M, dkk. Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis. BioMed Central. Crit Care. 2015;19:287.
Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, dkk. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387–93.
Essam AE, Sharif G, Al Hameed F. Venous thromboembolism related mortality and morbidity in King Fahd General Hospital, Jeddah, Kingdom of Saudi Arabia. Ann Thorac Med. 2011;6:193–8.
Bauer KA, Lip GYH. Overview of the causes of venous thrombosis. UpToDate. 2004;12:166.
Heraudeau A, Delluc A, Henaff ML, Lacut K, Leroyer C, Desreus B, dkk. Risk of venous thromboembolism in association with factor V leiden in cancer patient. Plos one. Barcelona. 2018;13:5.
Guyatt GH, Aki EA, Crowther M, Agnelli G, Bolis G, Capussotti;s L, dkk. Executive summary: antithrombotic therapy and prevention of thrombosis. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(Suppl):7–47S.
Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41:3–14.
Engbers MJ, Vlieg VH, Rosendaal FR. Venous thrombosis in elderly: incidence, risk and risk groups. J Thromb Haemost. 2010;8:2105–12.
Geerts WH, Bergqvist D, Pineo GF, Enoch S, Woon E. Prevention of venous thromboembolism. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2008;133(Suppl):381–453S.
King CS, Holley AB, Jackson JL, Nordstrom M, Lindblad B, Bergqvist D. Twice vs. three times daily heparin dosing for thromboembolism prophylaxis in the general medical population. a meta-analysis. Chest 2007;131:507–16.
Consortium for Spinal Cord Medicine. Prevention of venous thromboembolism in individual with spinal cord injury: clinical practice guidelines for health care provider. Top Spinal Cord Inj Rehabil. 2016;22(3):209–240.
Imberti D, Ageno W. A survey of thromboprophylaxis management in patients with major trauma. Pathophysiol Haemost Thromb. 2005;34:249–54.
Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral anticoagulants. Antithrombotic therapy and prevention of thrombosis. American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest. 2012;141(Suppl):24–43S.
Manoucheri R, Fallahi MJ. Adherence to venous thromboprophylaxis guidelines for medical and surgical inpatients of teaching hospital, Shiraz-Iran. National Institute of tuberculosis and lung disease. Iran: Tanaffos. 2015;14:17–26.
DOI: https://doi.org/10.15851/jap.v7n2.1739
Article Metrics
Abstract view : 881 timesPDF - 553 times
This Journal indexed by
JAP is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
View My Stats